Table 3

 Univariate analysis of prognostic factors

VariableHR95% CIp Value
CI, confidence interval; HR, hazard ratio.
Age (years)
    ⩽65 (n = 51)1
    >65 (n = 84)1.1300.737 to 1.7350.5749
Sex
    Male (n = 89)1
    Female (n = 46)1.0800.675 to 1.7290.7470
Primary tumour
    ⩽T2 (n = 20)1
    >T2 (n = 11)1.8461.018 to 3.3500.0436
Lymph node metastasis
    No (n = 59)1
    Yes (n = 76)1.5420.983 to 2.4200.0595
Distant metastasis
    No (n = 128)1
    Yes (n = 7)2.4381.049 to 5.6650.0383
Histological grade
    G1 (n = 37)1
    G2 (n = 73)1.1230.565 to 2.2310.7401
    G3 (n = 25)1.2800.676 to 2.4250.4483
Lymphatic invasion
    No (n = 9)1
    Yes (n = 126)3.2081.163 to 8.8460.0243
Venous invasion
    No (n = 35)1
    Yes (n = 100)1.0070.641 to 1.5840.9745
Perineural invasion
    No (n = 13)1
    Yes (n = 122)1.5200.725 to 3.1860.2673
Surgical margins
    Negative (n = 78)1
    Positive (n = 57)1.6081.038 to 2.4900.0333
MUC4 expression
    Low (<20%) (n = 114)1
    High (⩾20%) (n = 21)2.1271.240 to 3.6490.0061
ErbB2 expression
    Low (<20%) (n = 107)1
    High (⩾20%) (n = 28)1.1820.685 to 2.0390.5482
p27 expression
    Low (<20%) (n = 87)1
    High (⩾20%) (n = 48)1.4690.955 to 2.2580.0798
MUC1 expression
    Low (<20%) (n = 39)1
    High (⩾20%) (n = 96)1.0010.635 to 1.5990.9735